Concepedia

Publication | Open Access

Predictors of early response to infliximab in patients with ulcerative colitis

DOIFull Paper Access

190

Citations

28

References

2006

Year

Marc Ferrante, Séverine Vermeire, Maja Noman, Gert Van Assche, Fabian Schnitzler, Ingrid Arijs, Gert De Hertogh, Ilse Hoffman, Karel Geboes, Paul Rutgeerts
Inflammatory Bowel Diseases

Abstract

IFX is an efficient therapy in UC, as shown by 65% early clinical response. A pANCA+/ASCA- serotype and an older age at first IFX infusion are associated with a suboptimal early clinical response.

References

YearCitations

Page 1